Brief: Vicore Pharma Reports Q1 EBIT of SEK -66.1 Million
04/05/2023 07:24
May 4 (Reuters) - Vicore Pharma Q1 sales SEK 0. * Q1 EBIT SEK -66.1 million * Q1 adjusted EPS SEK -0.81 * Q1 net income SEK -66.3 million * Q1 adjusted free cash flow SEK -77.7 million * Q1 cash & investments SEK 183.6 million
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2